Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabiola Atzeni

Showing results (81-90 of 438) with videos related to

Pageof 44
Sort By:
Autoimmunity Reviews|July 25, 2025
Cardiovascular risk in psoriatic arthritis: How can we manage it?Fabiola Atzeni, Javier Rodríguez-Carrio, Alessandra Alciati, et al.
Journal of Clinical Medicine|November 13, 2020
The Co-Morbidity between Bipolar and Panic Disorder in Fibromyalgia SyndromeAlessandra Alciati, Fabiola Atzeni, Daniela Caldirola, et al.
Seminars in Arthritis and Rheumatism|October 7, 2005
Osteoarthritis of the spinePiercarlo Sarzi-Puttini, Fabiola Atzeni, Mario Fumagalli, et al.
Autoimmunity Reviews|January 26, 2011
Switching rheumatoid arthritis treatments: an updateFabiola Atzeni, Piercarlo Sarzi-Puttini, Roberto Gorla, et al.
Annals of the Rheumatic Diseases|September 3, 2010
Etanercept plus ciclosporin versus etanercept plus methotrexate for maintaining clinical control over psoriatic arthritis: a randomised pilot studyFabiola Atzeni, Laura Boccassini, Marco Antivalle, et al.
Clinical and Experimental Rheumatology|February 6, 2013
Changes in atherosclerosis markers during tocilizumab treatment in rheumatoid arthritis: preliminary resultsMaurizio Benucci, Mariangela Manfredi, Gianantonio Saviola, et al.
International Journal of Rheumatology|December 14, 2011
Cost effectiveness analysis of disease-modifying antirheumatic drugs in rheumatoid arthritis. A systematic review literatureMaurizio Benucci, Gianantonio Saviola, Mariangela Manfredi, et al.
Acta Bio-Medica : Atenei Parmensis|September 18, 2012
Tumor necrosis factors blocking agents: analogies and differencesMaurizio Benucci, Gianantonio Saviola, Mariangela Manfredi, et al.
Biomed Research International|June 21, 2014
Doctors' insights into the patient perspective: a qualitative study in the field of chronic painClaudia Zanini, Piercarlo Sarzi-Puttini, Fabiola Atzeni, et al.
Pharmacological Research|September 20, 2019
Il-6 Involvement in pain, fatigue and mood disorders in rheumatoid arthritis and the effects of Il-6 inhibitor sarilumabFabiola Atzeni, Valeria Nucera, Ignazio Francesco Masala, et al.
Pageof 44

Showing results (81-90 of 438) with videos related to

Sort By:
Pageof 44
Autoimmunity Reviews|July 25, 2025
Cardiovascular risk in psoriatic arthritis: How can we manage it?Fabiola Atzeni, Javier Rodríguez-Carrio, Alessandra Alciati, et al.
Journal of Clinical Medicine|November 13, 2020
The Co-Morbidity between Bipolar and Panic Disorder in Fibromyalgia SyndromeAlessandra Alciati, Fabiola Atzeni, Daniela Caldirola, et al.
Seminars in Arthritis and Rheumatism|October 7, 2005
Osteoarthritis of the spinePiercarlo Sarzi-Puttini, Fabiola Atzeni, Mario Fumagalli, et al.
Autoimmunity Reviews|January 26, 2011
Switching rheumatoid arthritis treatments: an updateFabiola Atzeni, Piercarlo Sarzi-Puttini, Roberto Gorla, et al.
Annals of the Rheumatic Diseases|September 3, 2010
Etanercept plus ciclosporin versus etanercept plus methotrexate for maintaining clinical control over psoriatic arthritis: a randomised pilot studyFabiola Atzeni, Laura Boccassini, Marco Antivalle, et al.
Clinical and Experimental Rheumatology|February 6, 2013
Changes in atherosclerosis markers during tocilizumab treatment in rheumatoid arthritis: preliminary resultsMaurizio Benucci, Mariangela Manfredi, Gianantonio Saviola, et al.
International Journal of Rheumatology|December 14, 2011
Cost effectiveness analysis of disease-modifying antirheumatic drugs in rheumatoid arthritis. A systematic review literatureMaurizio Benucci, Gianantonio Saviola, Mariangela Manfredi, et al.
Acta Bio-Medica : Atenei Parmensis|September 18, 2012
Tumor necrosis factors blocking agents: analogies and differencesMaurizio Benucci, Gianantonio Saviola, Mariangela Manfredi, et al.
Biomed Research International|June 21, 2014
Doctors' insights into the patient perspective: a qualitative study in the field of chronic painClaudia Zanini, Piercarlo Sarzi-Puttini, Fabiola Atzeni, et al.
Pharmacological Research|September 20, 2019
Il-6 Involvement in pain, fatigue and mood disorders in rheumatoid arthritis and the effects of Il-6 inhibitor sarilumabFabiola Atzeni, Valeria Nucera, Ignazio Francesco Masala, et al.
Pageof 44